KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Arbutus Biopharma (ABUS) Return on Equity: 2010-2025

Historic Return on Equity for Arbutus Biopharma (ABUS) over the last 14 years, with Sep 2025 value amounting to -0.53%.

  • Arbutus Biopharma's Return on Equity rose 14.00% to -0.53% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.53%, marking a year-over-year increase of 14.00%. This contributed to the annual value of -0.69% for FY2024, which is 9.00% down from last year.
  • Latest data reveals that Arbutus Biopharma reported Return on Equity of -0.53% as of Q3 2025, which was up 21.25% from -0.67% recorded in Q2 2025.
  • Arbutus Biopharma's Return on Equity's 5-year high stood at -0.44% during Q2 2022, with a 5-year trough of -0.87% in Q1 2025.
  • Over the past 3 years, Arbutus Biopharma's median Return on Equity value was -0.65% (recorded in 2024), while the average stood at -0.64%.
  • Per our database at Business Quant, Arbutus Biopharma's Return on Equity skyrocketed by 136bps in 2021 and then fell by 19bps in 2025.
  • Quarterly analysis of 5 years shows Arbutus Biopharma's Return on Equity stood at -0.51% in 2021, then rose by 2bps to -0.49% in 2022, then dropped by 15bps to -0.65% in 2023, then decreased by 4bps to -0.68% in 2024, then increased by 14bps to -0.53% in 2025.
  • Its Return on Equity was -0.53% in Q3 2025, compared to -0.67% in Q2 2025 and -0.87% in Q1 2025.